Loading...
CTVA logo

Corteva, Inc.NYSE:CTVA Aktienübersicht

Marktkapitalisierung US$53.2b
Aktienkurs
US$79.56
US$86.05
7.5% unterbewertet intrinsischer Abschlag
1Y15.2%
7D-1.9%
1D
Wert des Portfolios
Siehe

Corteva, Inc.

NYSE:CTVA Lagerbericht

Marktkapitalisierung: US$53.2b

CTVA Community Fair Values

Create Narrative

See what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.

Corteva, Inc. Wettbewerber

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für Corteva
Historische Aktienkurse
Aktueller AktienkursUS$79.56
52-Wochen-HochUS$85.63
52-Wochen-TiefUS$60.54
Beta0.59
1 Monat Veränderung-0.30%
3 Monate Veränderung2.04%
1 Jahr Veränderung15.20%
3 Jahre Veränderung44.21%
5 Jahre Veränderung74.86%
Veränderung seit IPO220.68%

Aktuelle Nachrichten und Updates

Analyseartikel May 14

Corteva's (NYSE:CTVA) Performance Is Even Better Than Its Earnings Suggest

Even though Corteva, Inc.'s ( NYSE:CTVA ) recent earnings release was robust, the market didn't seem to notice...

Recent updates

Analyseartikel May 14

Corteva's (NYSE:CTVA) Performance Is Even Better Than Its Earnings Suggest

Even though Corteva, Inc.'s ( NYSE:CTVA ) recent earnings release was robust, the market didn't seem to notice...
Narrativ-Update Apr 27

CTVA: Fair Value View Weighs Crop Protection Uncertainty And Planned SpinCo Separation

Corteva's analyst price target has increased by about $2, as analysts cite updated earnings models, a revised fair value of $86.05, a slightly adjusted discount rate, and modest changes to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Corteva has been active, with several price target revisions and a mix of ratings changes that give you both supportive and cautious signals to weigh.
Narrativ-Update Apr 13

CTVA: Fair Value View Balances Crop Protection Risks And Upcoming SpinCo Separation

The analyst price target for Corteva has moved modestly higher to align with a fair value estimate of about $84, as analysts factor in updated earnings models, slightly adjusted revenue growth and profit margin assumptions, and recent price target changes across several firms. Analyst Commentary Recent Street research on Corteva shows a mix of higher price targets and a few rating downgrades, so you are seeing both optimism and caution reflected in the current analyst debate.
Narrativ-Update Mar 28

CTVA: Crop Protection Uncertainty And SpinCo Separation Will Shape Future Risk Balance

The analyst price target for Corteva has been nudged higher, with a modest fair value uplift to $83.95 as analysts balance a series of recent target increases from multiple firms against more cautious views tied to softer crop protection trends. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on near term fundamentals, especially in crop protection.
Narrativ-Update Mar 12

CTVA: Mixed Crop Protection Outlook And New SpinCo Plan Will Shape Risk Balance

The analyst price target for Corteva edges higher to $83.33 from $82.76, as analysts factor in slightly firmer long term revenue growth and profit margins, while balancing more cautious views on crop protection trends and a modestly lower discount rate. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on execution in crop protection.
Narrativ-Update Feb 26

CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance

Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.
Narrativ-Update Feb 11

CTVA: Mixed Sector Backdrop And New Ventures Will Shape Future Prospects

Corteva's analyst fair value estimate has increased to $82.05 from $78.43 as analysts factor in slightly stronger revenue growth assumptions, a higher future P/E multiple, and a modestly lower discount rate, even as projected profit margins are trimmed. Analyst Commentary Recent Street research on Corteva is mixed, with several bullish analysts lifting price targets while a few high profile firms turn more cautious.
Narrativ-Update Jan 26

CTVA: Seed And Crop Protection Split Will Shape Balanced Future Prospects

Narrative Update Analysts have modestly raised their price expectations for Corteva, with the updated fair value estimate moving by about US$0.48 per share. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E, and is supported by recent target increases from several firms.
Narrativ-Update Jan 11

CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power

Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.
Seeking Alpha Jan 10

Corteva: Get Your Piece Of SpinCo As A Stable Portfolio Compounder

Summary Corteva is splitting into two pure-play companies, with the seed segment (SpinCo) offering superior stability and margin profile. I rate CTVA a buy, driven by SpinCo's consistent revenue growth, high operating margins (26%), and robust market position in seeds, especially corn. SpinCo trades at an implied 9.3x EV/EBITDA, below sector and CTVA's historical average, with potential for significant buybacks and dividend increases post-separation. Key risk is U.S. isolationism; deteriorating U.S.-China trade could impact corn and soybean sales, potentially altering the investment thesis. Read the full article on Seeking Alpha
Narrativ-Update Dec 18

CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power

The analyst price target for Corteva has been nudged higher by approximately $0.05 to about $77.76, as analysts factor in a slightly lower discount rate and modestly improved long term growth expectations, despite broadly cautious sector commentary and recent target reductions. Analyst Commentary Street research on Corteva reflects a divided but generally constructive view, with price targets drifting lower but ratings remaining skewed toward positive as investors reassess the company’s post breakup trajectory and near term earnings backdrop.
Narrativ-Update Dec 03

CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power

Our analyst price target for Corteva has been trimmed modestly in line with recent Street moves, as analysts factor in lower sector multiples and near term earnings uncertainty around the planned split, while still recognizing the company’s intact innovation engine and long term earnings growth potential. Analyst Commentary Street views on Corteva have become more bifurcated following the announced split, with valuation targets reset lower but ratings broadly supportive of the long term strategic rationale and earnings power.
Analyseartikel Nov 26

A Look At The Fair Value Of Corteva, Inc. (NYSE:CTVA)

Key Insights Corteva's estimated fair value is US$63.85 based on 2 Stage Free Cash Flow to Equity Current share price...
Narrativ-Update Nov 19

CTVA: Upcoming Seed And Pesticide Split Will Unlock Shareholder Value

The analyst consensus price target for Corteva has been modestly reduced, slipping from approximately $77.86 to $77.71. Analysts reflect more cautious expectations for earnings growth in light of a mixed agricultural outlook and anticipated impacts from the company's planned business split.
Narrativ-Update Nov 05

CTVA: Share Split Will Drive Shareholder Value Unlocking Amid Ongoing Business Realignment

Analysts have modestly reduced their average price target for Corteva by approximately $1.20. They cite a more cautious outlook amid challenging crop protection conditions and the company's recent announcement to split into two separate businesses.
Narrativ-Update Oct 22

Analysts Offer Mixed Views as Corteva Eyes Split and Updates Guidance Amid Modest Valuation Shift

Analysts have modestly reduced their price target for Corteva by about $0.76 to $79.05. They cite uncertainty regarding the company’s planned split and the retention of legacy liabilities, though fundamentals and growth remain largely stable.
Narrativ-Update Oct 08

High-Yield Seed Demand And Eco Policies Will Transform Agriculture

Corteva's analyst price target has been modestly reduced by $0.95 per share. Analysts cite continued uncertainty around the planned corporate split and complex crop protection market dynamics.
Narrativ-Update Sep 04

High-Yield Seed Demand And Eco Policies Will Transform Agriculture

Analysts maintained their price target for Corteva at $80.76, citing margin expansion and EBITDA growth driven by successful innovation, favorable market fundamentals, and strong execution. Analyst Commentary Ongoing cost reductions, successful innovation, and strong execution are driving margin expansion and double-digit EBITDA growth.
Analyseartikel Aug 26

Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year

Corteva, Inc. ( NYSE:CTVA ) will increase its dividend from last year's comparable payment on the 15th of September to...
Analyseartikel Aug 01

Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year

Corteva, Inc. ( NYSE:CTVA ) will increase its dividend on the 15th of September to $0.18, which is 5.9% higher than...
Analyseartikel Jul 28

Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings

With a price-to-earnings (or "P/E") ratio of 43.9x Corteva, Inc. ( NYSE:CTVA ) may be sending very bearish signals at...
Analyseartikel Jul 14

We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha Apr 21

Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance

Summary Upgrading Corteva from Buy to Strong Buy due to macro conditions, including tariff-induced supply shocks, rising commodity prices, and currency tailwinds. Corteva's diversified supply chain and local production in seeds position it to benefit from regionalization and potential inflationary pressures in the agricultural sector. Strong Q4 earnings, record operating EBITDA margin, and robust free cash flow support the bullish outlook, with significant shareholder returns through dividends and buybacks. Improved valuation at 20x forward earnings, solid balance sheet, and technical indicators suggest potential for further upside in the current market environment. Read the full article on Seeking Alpha
Seeking Alpha Mar 30

Pure Market Inefficiency In Corteva Preferreds Pricings

Summary This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio. On 02/10/2025, technical high-volume buying in CTA-A turned our initial investment idea into a pair trade. This pair trade highlights how technical factors can create profitable opportunities in fixed-income securities, especially among identical issues from the same issuer. Read the full article on Seeking Alpha
Seeking Alpha Feb 09

CTA.PR.B: An Undervalued Investment-Grade Opportunity From Corteva

Summary CTA-B offers a 6.32% current yield, making it an attractive investment-grade preferred stock with solid financial backing from Corteva, Inc. Corteva, Inc.'s strong financial health and low leverage ensure the safety of uninterrupted dividend distributions for CTA-B shareholders. Comparative analysis shows CTA-B is undervalued, offering a potential 10% capital appreciation relative to its peers and Corteva's OTC bonds. Corteva's BBB credit rating and low-risk perception in the bond market further reinforce the security and value of investing in CTA-B. Read the full article on Seeking Alpha
Seeking Alpha Jan 10

Corteva: A Wide-Moat Play On Commodity Prices

Summary Corteva is a strong defensive play for stagflation with its wide economic moat in seeds, providing exposure to agricultural commodities and a growing dividend. The company has shown impressive performance since its 2019 spin-off, with growth in gross profits and operating income exceeding revenue growth, reflecting strong operating efficiency. Corteva faces risks such as regulatory and ESG concerns, pricing pressure in crop protection, and currency fluctuations, but remains a resilient and diversified investment. I rate Corteva a "Buy" for its defensive characteristics, allowing investors to gain commodity exposure as a best-in-breed operator. Read the full article on Seeking Alpha

Aktionärsrenditen

CTVAUS ChemicalsUS Markt
7D-1.9%0.5%1.1%
1Y15.2%8.9%28.7%

Rendite im Vergleich zur Industrie: CTVA übertraf die Branche US Chemicals , die im vergangenen Jahr eine Rendite von 8.9 erzielte.

Rendite vs. Markt: CTVA hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 28.7 erzielte.

Preisvolatilität

Is CTVA's price volatile compared to industry and market?
CTVA volatility
CTVA Average Weekly Movement3.3%
Chemicals Industry Average Movement7.4%
Market Average Movement7.2%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.1%

Stabiler Aktienkurs: CTVA hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: CTVADie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
180221,500Chuck Magrowww.corteva.com

Corteva, Inc. ist im Bereich der Landwirtschaft tätig. Das Unternehmen ist in zwei Segmenten tätig: Saatgut und Pflanzenschutz. Das Segment Saatgut entwickelt und liefert fortschrittliches Keimplasma und Traits, die optimale Erträge für landwirtschaftliche Betriebe liefern.

Corteva, Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Corteva im Vergleich zum Marktanteil des Unternehmens?
CTVA grundlegende Statistiken
MarktanteilUS$53.21b
Gewinn(TTM)US$1.25b
Umsatz(TTM)US$17.89b
42.5x
Kurs-Gewinn-Verhältnis
3.0x
Kurs-Umsatz-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
CTVA Gewinn- und Verlustrechnung (TTM)
EinnahmenUS$17.89b
Kosten der EinnahmenUS$9.20b
BruttogewinnUS$8.69b
Sonstige AusgabenUS$7.44b
GewinnUS$1.25b

Zuletzt gemeldete Gewinne

Mar 31, 2026

Datum des nächsten Gewinnberichts

Jul 30, 2026

Gewinn per Aktie (EPS)1.87
Bruttomarge48.56%
Nettogewinnspanne7.00%
Schulden/Eigenkapital-Verhältnis13.6%

Wie hat sich CTVA auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.9%
Aktuelle Dividendenrendite
39%
Ausschüttungsquote

Zahlt CTVA eine zuverlässige Dividende?

Siehe CTVA Dividendenhistorie und Benchmarks
Bis wann müssen Sie CTVA kaufen, um eine kommende Dividende zu erhalten?
Corteva Dividendentermine
Ex-Dividenden DatumJun 01 2026
Datum der DividendenzahlungJun 15 2026
Tage bis Ex-Dividende6 days
Tage bis zum Datum der Dividendenzahlung20 days

Zahlt CTVA eine zuverlässige Dividende?

Siehe CTVA Dividendenhistorie und Benchmarks

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/25 13:55
Aktienkurs zum Tagesende2026/05/22 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Corteva, Inc. wird von 39 Analysten beobachtet. 19 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
null nullArgus Research Company
Benjamin TheurerBarclays
Benjamin TheurerBarclays